loadpatents
name:-0.033783912658691
name:-0.025193929672241
name:-0.0010709762573242
Cheresh; David A. Patent Filings

Cheresh; David A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheresh; David A..The latest application filed is for "compositions for detecting circulating integrin beta-3 biomarker and methods for detecting cancers and assessing tumor presence or progression, cancer drug resistance and tumor stemness".

Company Profile
0.24.28
  • Cheresh; David A. - La Jolla CA
  • CHERESH; David A. - Encinitas CA
  • Cheresh, David A. - Eucinitas CA
  • Cheresh; David A. - Cardiff CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype
Grant 11,052,089 - Cheresh , et al. July 6, 2
2021-07-06
Compositions For Detecting Circulating Integrin Beta-3 Biomarker And Methods For Detecting Cancers And Assessing Tumor Presence Or Progression, Cancer Drug Resistance And Tumor Stemness
App 20180203014 - CHERESH; David A. ;   et al.
2018-07-19
Methods For Inhibiting Alpha-v Beta-3 Expression On Cancer Stem Cells And Inhibiting Progression To A Cancer Stem Cell Phenotype
App 20180000821 - CHERESH; David A. ;   et al.
2018-01-04
Therapeutic Methods And Compositions Involving Allosteric Kinase Inhibition
App 20160237064 - MURPHY; Eric A. ;   et al.
2016-08-18
Therapeutic methods and compositions involving allosteric kinase inhibition
Grant 9,260,417 - Murphy , et al. February 16, 2
2016-02-16
Therapeutic Methods And Compositions Involving Allosteric Kinase Inhibition
App 20140296268 - Murphy; Eric A. ;   et al.
2014-10-02
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
Grant 7,833,976 - Lode , et al. November 16, 2
2010-11-16
Compositions And Methods For Reducing Cancer And Inflammation
App 20100278837 - Varner; Judith A. ;   et al.
2010-11-04
Delivery system for nucleic acids
Grant 7,803,399 - Cheresh , et al. September 28, 2
2010-09-28
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
Grant 7,595,051 - Brooks , et al. September 29, 2
2009-09-29
Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
Grant 7,585,841 - Cheresh , et al. September 8, 2
2009-09-08
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
App 20090060864 - Lode; Holger N. ;   et al.
2009-03-05
Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies
Grant 7,482,007 - Brooks , et al. January 27, 2
2009-01-27
Method of treatment of myocardial infarction
App 20080200481 - Cheresh; David A. ;   et al.
2008-08-21
Methods for treating angiogenesis related disorders
App 20080175840 - Brooks; Peter ;   et al.
2008-07-24
Methods for inhibiting angiogenesis and tumor growth
Grant 7,368,478 - Boger , et al. May 6, 2
2008-05-06
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
Grant 7,365,054 - Lode , et al. April 29, 2
2008-04-29
Methods of treating arthritis and diabetic retinopathy with .alpha..sub.v.beta..sub.3-specific antibodies
Grant 7,354,586 - Brooks , et al. April 8, 2
2008-04-08
Methods of treating psoriasis with .alpha..sub.v.beta..sub.3-specific antibodies
Grant 7,329,406 - Brooks , et al. February 12, 2
2008-02-12
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
App 20070036751 - Lode; Holger N. ;   et al.
2007-02-15
Methods for inhibition of angiogenesis
App 20060270710 - Brooks; Peter C. ;   et al.
2006-11-30
Method of treatment of myocardial infarction
App 20060258686 - Cheresh; David A. ;   et al.
2006-11-16
Peptide-based angiogenesis inhibitors and methods of use thereof
Grant 7,125,849 - Cheresh , et al. October 24, 2
2006-10-24
Methods for inhibiting angiogenesis and tumor growth
Grant 7,115,660 - Boger , et al. October 3, 2
2006-10-03
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
Grant 7,115,261 - Lode , et al. October 3, 2
2006-10-03
Methods for inhibiting angiogenesis and tumor growth
App 20060211769 - Boger; Dale L. ;   et al.
2006-09-21
Delivery system for nucleic acids
App 20060188560 - Cheresh; David A. ;   et al.
2006-08-24
Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
App 20060165703 - Brooks; Peter ;   et al.
2006-07-27
Methods and compositions useful for inhibition of .alpha..sub.v.beta..sub.5mediated angiogenesis
Grant 7,053,041 - Brooks , et al. May 30, 2
2006-05-30
Delivery system for nucleic acids
Grant 7,025,987 - Cheresh , et al. April 11, 2
2006-04-11
Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
App 20060040853 - Hood; John ;   et al.
2006-02-23
Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
App 20060009412 - Cheresh; David A. ;   et al.
2006-01-12
Inhibition of angiogenesis in disease states with an anti-.alpha.v.beta.3 monoclonal antibody
Grant 6,887,473 - Brooks , et al. May 3, 2
2005-05-03
Methods and compositions useful for inhibition of angiogenesis
App 20050002936 - Brooks, Peter C. ;   et al.
2005-01-06
Methods and compositions useful for inhibition of angiogenesis
App 20040265317 - Brooks, Peter ;   et al.
2004-12-30
Methods and compositions useful for inhibition of angiogenesis
App 20040258691 - Brooks, Peter ;   et al.
2004-12-23
Method of treatment of myocardial infarction
App 20040214836 - Cheresh, David A. ;   et al.
2004-10-28
Inhibition of angiogenesis and tumor growth
Grant 6,803,383 - Boger , et al. October 12, 2
2004-10-12
Peptide-based angiogenesis inhibitors and methods of use thereof
App 20040138133 - Cheresh, David A. ;   et al.
2004-07-15
Methods for inhibition of angiogenesis
App 20040063790 - Brooks, Peter C. ;   et al.
2004-04-01
Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases
Grant 6,685,938 - Cheresh , et al. February 3, 2
2004-02-03
Methods and compositions useful for inhibition of angiogenesis
App 20030176334 - Brooks, Peter ;   et al.
2003-09-18
Method of treatment of myocardial infarction
App 20030130209 - Cheresh, David A. ;   et al.
2003-07-10
Delivery system for nucleic acids
App 20030092655 - Cheresh, David A. ;   et al.
2003-05-15
Inhibition of angiognenesis and tumor growth
App 20030083519 - Boger, Dale L. ;   et al.
2003-05-01
Methods for inhibiting angiogenesis and tumor growth
App 20030078296 - Boger, Dale L. ;   et al.
2003-04-24
Methods and compositions useful for inhibition of angiogenesis
Grant 6,500,924 - Brooks , et al. December 31, 2
2002-12-31
Cyclic adhesion inhibitors
Grant 5,866,540 - Jonczyk , et al. February 2, 1
1999-02-02
Methods and compositions useful for inhibition of angiogenesis
Grant 5,766,591 - Brooks , et al. June 16, 1
1998-06-16
Methods and compositions useful for inhibition of angiogenesis
Grant 5,753,230 - Brooks , et al. May 19, 1
1998-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed